United States News Todas as matérias

SemiLEDs (NASDAQ:LEDS) reported fiscal Q3 2026 revenue of $9.1 million and net income of $1.5 million, reversing the previous quarter’s loss.

Nayax (NASDAQ:NYAX) completed technical remediation and cleared its systems of unauthorized access following a July 2026 security incident.

Google parent Alphabet (NASDAQ:GOOGL) faces a Swiss preliminary investigation after Google removed Android’s Choice Screen in a market where it holds an estimated 82% search share.

BP (NYSE:BP) expects stronger oil realizations to add US$1.8 billion–US$2.1 billion to second-quarter upstream earnings despite production falling to 2.17 million–2.22 million boe/d.

Brent crude rose US$2.74, or 3.29%, to US$86.04, while West Texas Intermediate crude gained US$2.21, or 2.83%, to US$80.35 as renewed U.S.-Iran attacks threatened Strait of Hormuz energy flows.

Mesoblast (NASDAQ:MESO) treated at least 300 patients in MSB-DR004, reaching the pivotal Phase 3 treatment target for rexlemestrocel-L in chronic low back pain.

SILITH Technology and United Microelectronics (NYSE:UMC) delivered the first mass-produced photonic integrated circuit wafers from UMC’s Singapore fab for SILITH’s 1.6T silicon photonics platform.

VEON (NASDAQ:VEON) completed its acquisition of 76.33% of TPL Insurance for approximately PKR 4.55 billion, or US$16.4 million.

WISeKey (NASDAQ:WKEY) reported preliminary H1 2026 revenue of approximately US$11.4 million, up 115%, while its cash and short-term investments reached about US$495 million with zero debt.

Grupo Aeroportuario del Pacifico (NYSE:PAC) reported 2Q26 revenue of Ps. 11,289.7 million, up 3.7%, as EBITDA rose 8.4% and net income increased 9.0% following the CBX combination.

ProMIS Neurosciences (NASDAQ:PMN) reported first human evidence that PMN310 reduced detectable amyloid-beta oligomers in cerebrospinal fluid dose-dependently at days three and 29, providing an exploratory signal that the antibody reached and engaged its intended target.

Twelve US states have filed a lawsuit in an Oakland federal court to block Paramount's proposed US$110 billion acquisition of Warner Bros Discovery (NASDAQ:WBD).

The United States government reimposed a naval blockade on Iranian commerce through the Strait of Hormuz and announced a 20% toll.

Paramount (NASDAQ:PSKY) faces a lawsuit from California and 11 other states seeking to block its proposed $110 billion acquisition of Warner Bros. Discovery (NASDAQ:WBD), with regulators alleging the deal could reduce competition in entertainment markets.

President Donald Trump said the United States was reinstating a naval blockade on Iran after Tehran claimed it had closed the Strait of Hormuz, a major global oil shipping route.

Intel (NASDAQ:INTC) announced a €5 billion ($5.7 billion) capital investment at its Leixlip campus in Ireland to expand production of data center processors supporting artificial intelligence and high-performance computing demand.

Halliburton (NYSE:HAL) secured major integrated well construction contracts for the GranMorgu deepwater development offshore Suriname, operated by TotalEnergies, covering drilling and completion services under a long-term program.

Artelo Biosciences (NASDAQ:ARTL) reported new nonclinical data showing ART27.13 reduced neuropathic pain-associated behaviors in a paclitaxel-induced peripheral neuropathy model in male and female animals.

BioMarin Pharmaceutical (NASDAQ:BMRN) announced that the U.S. Food and Drug Administration accepted its supplemental New Drug Application for full approval of VOXZOGO (vosoritide) in children with achondroplasia, with an FDA decision target date of February 28, 2027.

Virtus Investment Partners (NYSE:VRTS) reported preliminary assets under management of $152.2 billion and other fee-earning assets of $1.7 billion, bringing total client assets to $153.9 billion as of June 30, 2026.

Voyager Therapeutics (NASDAQ:VYGR) reported six-month toxicology results for VY1706, its investigational tau-targeted gene therapy for Alzheimer’s disease, showing s

Edgewise Therapeutics (NASDAQ:EWTX) completed the sale of sevasemten and its muscular dystrophy business to Servier for $1.55 billion in upfront cash and up to $1.1 billion in potential regulatory and commercial milestones.

Clearmind Medicine (NASDAQ:CMND) shared early insights from its ongoing Phase I/IIa trial of CMND-100, an investigational MEAI-based compound being evaluated for alcohol use disorder, following a June 10 webinar with study investigators from Yale and Johns Hopkins.

SLB (NYSE:SLB) announced that its OneSubsea joint venture was awarded a major engineering, procurement and construction contract by Eni for Phase 3 of the deepwater Baleine project offshore Côte d’Ivoire, covering subsea production systems for 13 wells.